Welcome readers, we are currently gathering a database and you will be able to enjoy PlexPage starting June 1st fully. In the meantime, please check out the web.plex.page and scholar.plex.page.

Omalizumab Injection

Summarized by Plex Health
Last Updated: 22 February 2022

Omalizumab injection is made use of to decrease the variety of bronchial asthma assaults in youngsters and grownups 6 years of age and older with sensitive asthma whose signs are not managed with inhaled steroids. Omalizumab is also made use of to treat persistent hives without a well-known cause that can not efficiently be treated with antihistamine medications such as diphenhydramine, cetirizine, hydroxyzine, and loratadine in kids and adults 12 years of age and older. Omalizumab injection is in a course of medicines called monoclonal antibodies.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.